HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV Prevention
South Africa in the news: HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV Prevention: HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV Prevention GlobeNewswire December 21, 2021 DURHAM, N.C., Dec. 21, 2021 …: “South Africa” – BingNews Jos Buttler, AB De Villiers & more – …